IP Library Granted Patent US 8,080,259
Granted Patent B2
US 8,080,259 · App. 12/655,399 · Granted Dec 20, 2011

Sustained delivery of an active agent using an implantable system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,080,259
App. No.
12/655,399
Granted
Dec 20, 2011
Kind
B2
Abstract

The invention is directed to a device for delivering an active agent formulation for a predetermined administration period. An impermeable reservoir is divided into a water-swellable agent chamber and an active agent formulation chamber. Fluid from the environment is imbibed through a semipermeable plug into the water-swellable agent chamber and the active agent formulation is released through a back-diffusion regulating outlet. Delivery periods of up to 2 years are achieved.

Claims (32)

1. A method of assembling components to form an implantable, fluid-imbibing device for delivering an active agent to a fluid environment of use, comprising:

providing an impermeable reservoir comprising an interior surface;

inserting a piston into the reservoir to divide the reservoir into a water-swellable agent chamber and an active agent chamber, wherein the water-swellable agent chamber has an open end and the active agent formulation chamber has an open end;

inserting a water-swellable agent into the water-swellable agent chamber of the reservoir;

inserting a water-swellable semipermeable plug into the open end of the water-swellable agent chamber of the reservoir, wherein the semipermeable plug is received in sealing relationship with the interior surface of the reservoir;

inserting an active agent formulation into the active agent formulation chamber of the reservoir; and

inserting a back diffusion regulating outlet into the open end of the active agent formulation chamber of the reservoir, wherein the reservoir interior surface and back diffusion regulating outlet have surfaces in a mating relationship.

2. The method of claim 1 , wherein the reservoir interior surface and back diffusion regulating outlet have surfaces in a mating relationship, a helical flow path for the active agent formulation is formed between the mating surfaces, a length of the helical flow path is sufficient to prevent back-diffusion of external fluid through the helical flow path, and the helical flow path has a length of about 2 cm to about 7 cm.

3. The method of claim 1 , wherein the reservoir interior surface and back diffusion regulating outlet have surfaces in a mating relationship, a helical flow path for the active agent formulation is formed between the mating surfaces, a length of the helical flow path is sufficient to prevent back-diffusion of external fluid through the helical flow path, and the helical flow path has a diameter of about 0.001 inches to about 0.020 inches.

4. The method of claim 1 , further comprising lubricating the interior surface of the reservoir and the piston before inserting the piston into the reservoir.

5. The method of claim 4 , wherein a silicon medical fluid is used for the lubricating.

6. The method of claim 1 , wherein the water-swellable agent for inserting into the water-swellable agent chamber of the reservoir comprises two tablets comprising sodium chloride.

7. The method of claim 6 , further comprising adding an additive to the water-swellable agent chamber to exclude air from spaces around the water-swellable agent.

8. The method of claim 7 , wherein the additive is polyethylene glycol.

9. The method of claim 1 , wherein one or more components is sterilized.

10. The method of claim 9 , wherein the one or more components is sterilized using gamma radiation, steam sterilization or sterile filtration.

11. The method of claim 1 , wherein the semipermeable plug comprises a material selected from the group consisting of plasticized cellulosic materials, polyurethanes, hydroxyethylmethacrylate, polyether-polyamide copolymers, and polyamides.

12. The method of claim 1 , wherein the reservoir comprises titanium or a titanium alloy.

13. The method of claim 1 , wherein the piston comprises an elastomeric material.

14. The method of claim 1 , wherein the piston comprises a material selected from the group consisting of polypropylene, EPDM, silicone rubber, butyl rubber, plasticized polyvinylchloride, and polyurethanes.

15. The method of claim 1 , wherein the back diffusion regulating outlet comprises a polymer.

16. An implantable, fluid-imbibing device for delivering an active agent to a fluid environment of use, said device comprising the following components:

an impermeable reservoir comprising an interior surface;

a piston that divides the reservoir into a water-swellable agent chamber and an active agent chamber, wherein the water-swellable agent chamber has an open end and the active agent formulation chamber has an open end;

a back diffusion regulating outlet received in the open end of the active agent formulation chamber of the reservoir for delivering fluid from the active agent formulation chamber to the fluid environment, the reservoir interior surface and back diffusion regulating outlet having surfaces in a mating relationship; and

a water-swellable semipermeable plug received in sealing relationship with the interior surface of the open end of the water-swellable agent chamber of the reservoir, wherein the semipermeable plug imbibes between about 0.1% and about 200% by weight of water.

17. The implantable, fluid-imbibing device of claim 16 , wherein the semipermeable plug has an aspect ratio of between 1:10 and 10:1 length to diameter.

18. The implantable, fluid-imbibing device of claim 17 , wherein the semipermeable plug has an aspect ratio of between 7:10 and 2:1 length to diameter.

19. The implantable, fluid-imbibing device of claim 17 , wherein the semipermeable plug has an aspect ratio of about 1:2 length to diameter.

20. The implantable, fluid-imbibing device of claim 16 , wherein the reservoir interior surface and back diffusion regulating outlet have surfaces in a mating relationship, a helical flow path for the active agent formulation is formed between the mating surfaces, a length of the helical flow path is sufficient to prevent back-diffusion of external fluid through the helical flow path, and the helical flow path has a length of about 2 to about 7 cm.

21. The implantable, fluid-imbibing device of claim 16 , wherein the reservoir interior surface and back diffusion regulating outlet have surfaces in a mating relationship, a helical flow path for the active agent formulation is formed between the mating surfaces, a length of the helical flow path is sufficient to prevent back-diffusion of external fluid through the helical flow path, and the helical flow path has a diameter of about 0.001 to about 0.020 inches.

22. The implantable, fluid-imbibing device of claim 16 , wherein the semipermeable plug comprises a material selected from the group consisting of plasticized cellulosic materials, polyurethanes, hydroxyethylmethacrylate, polyether-polyamide copolymers, and polyamides.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Oct 23, 2015
From: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 036942/0544 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 6, 2015
From: PEERY, JOHN R.; DIONNE, KEITH E.; ECKENHOFF, EXECUTRIX OF THE ESTATE OF JAMES B. ECKENHOFF, DECEASED, BONNIE J.; LANDRAU, FELIX A.; LAUTENBACH, SCOTT D.; MAGRUDER, JUDY A.; WRIGHT, JEREMY C.
To: ALZA CORPORATION
Reel/Frame 035107/0175 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 6, 2015
From: ALZA CORPORATION
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 035108/0049 →
SECURITY AGREEMENT Recorded Nov 14, 2012
From: INTARCIA THERAPEUTICS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 029299/0678 →
RELEASE OF SECURITY INTEREST Recorded Sep 23, 2011
From: OXFORD FINANCE CORPORATION; SILICON VALLEY BANK
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 026962/0062 →
SECURITY AGREEMENT Recorded Sep 8, 2010
From: INTARCIA THERAPEUTICS, INC.
To: OXFORD FINANCE CORPORATION; SILICON VALLEY BANK
Reel/Frame 024953/0525 →